Acetaminosalol

Acetaminosalol

SCHEMBL579853

CC(=O)Nc1ccc(OC(=O)c2ccccc2O)cc1.[AlH3]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.97
HSD17B10 Q99714 3/20 0.97
ALDH1A1 P00352 3/20 0.70
KDM4E B2RXH2 2/20 0.70
GLA P06280 1/20 0.70
ALOX15 P16050 1/20 0.61
KMT2A Q03164 8/20 0.58
MEN1 O00255 4/20 0.58
MAPT P10636 2/20 0.55
TSHR P16473 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 2/20 0.51
PNLIP P16233 3/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaminosalol SCHEMBL30383652 0.98 HPGD (1.00) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL25220 0.98 HPGD (1.00) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL2521697 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL8667882 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL4777453 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL579851 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL18149032 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL4780360 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL27692402 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL3041383 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703702-B2 Production system/production process for acrylic acid and precursors thereof NOVOMER, INC. (US) 2020-07-07 US claimed
WO-2017023777-A9 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF NOVOMER, INC. (US) 2017-10-12 WO claimed
WO-2017023820-A1 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF NOVOMER, INC. (US) 2017-02-09 WO claimed
WO-2017023777-A1 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF NOVOMER, INC. (US) 2017-02-09 WO claimed
US-20170029352-A1 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF NOVOMER, INC. 2017-02-02 US claimed
EP-3798247-B1 PROCESS AND SYSTEM FOR PRODUCTION OF POLYPROPIOLACTONE NOVOMER INC (US) 2024-04-17 EP disclosed
EP-3256442-B1 SYSTEMS AND PROCESSES FOR POLYACRYLIC ACID PRODUCTION NOVOMER INC (US) 2023-11-22 EP disclosed
US-11667617-B2 Catalyst recycle methods NOVOMER, INC. (US) 2023-06-06 US disclosed
US-20230085963-A1 PROCESS AND SYSTEM FOR PRODUCTION OF POLYPROPIOLACTONE NOVOMER, INC. 2023-03-23 US disclosed
US-20220251018-A1 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF NOVOMER, INC. 2022-08-11 US disclosed
EP-3941613-A1 MEMBRANE SEPARATION SYSTEM, AND USES THEREOF Novomer, Inc. (US) 2022-01-26 EP disclosed
US-11027242-B2 Nanofiltration membranes and methods of use NOVOMER, INC. (US) 2021-06-08 US disclosed
US-8796475-B2 Process for beta-lactone production NOVOMER, INC. (US) 2014-08-05 US disclosed
WO-2014008232-A2 PROCESS FOR ACRYLATE PRODUCTION NOVOMER, INC. (US) 2014-01-09 WO disclosed
US-20130281715-A1 PROCESS FOR BETA-LACTONE PRODUCTION NOVOMER, INC. 2013-10-24 US disclosed
WO-2013122905-A1 PROCESS FOR THE PRODUCTION OF ACID ANHYDRIDES FROM EPOXIDES NOVOMER, INC. (US) 2013-08-22 WO disclosed
US-8445703-B2 Process for beta-lactone production NOVOMER, INC. (US) 2013-05-21 US disclosed
US-20120123137-A1 PROCESS FOR BETA-LACTONE PRODUCTION NOVOMER, INC. (US) 2012-05-17 US disclosed
EP-2417182-A1 PROCESS FOR BETA-LACTONE PRODUCTION Novomer, Inc. (US) 2012-02-15 EP disclosed
WO-2010118128-A1 PROCESS FOR BETA-LACTONE PRODUCTION NOVOMER, INC. (US) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123137-A1 PROCESS FOR BETA-LACTONE PRODUCTION AGL, DCXR, CBR1 HPGD 201/4885HSD17B10 147/4885ALDH1A1 695/4885
US-10703702-B2 Production system/production process for acrylic acid and precursors thereof PCCA, COASY, ALAD HPGD 38/4885HSD17B10 168/4885ALDH1A1 520/4885
US-20220251018-A1 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF COASY, ALAD, PCCA HPGD 21/4885HSD17B10 197/4885ALDH1A1 664/4885
US-20170029352-A1 PRODUCTION SYSTEM/PRODUCTION PROCESS FOR ACRYLIC ACID AND PRECURSORS THEREOF PCCA, COASY, ALAD HPGD 38/4885HSD17B10 168/4885ALDH1A1 520/4885
US-11667617-B2 Catalyst recycle methods CBR1, CBR3, EPHX2 HPGD 313/4885HSD17B10 496/4885ALDH1A1 58/4885
US-11027242-B2 Nanofiltration membranes and methods of use MLEC, EPCAM, LNPK HPGD 2068/4885HSD17B10 3295/4885ALDH1A1 1130/4885
US-20130281715-A1 PROCESS FOR BETA-LACTONE PRODUCTION AGL, DCXR, CBR1 HPGD 201/4885HSD17B10 147/4885ALDH1A1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.